Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis

X. Saez-Llorens, O. Ramilo, M. M. Mustafa, J. Mertsola, C. De Alba, E. Hansen, G. H. McCracken

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Pentoxifylline has been shown to decrease endotoxin-induced tumor necrosis factor alpha production and reverse the inflammatory actions of interleukin-1 (IL-1) and tumor necrosis factor on leukocyte function. Because of the potential role of this cytokine-leukocyte interaction in the pathogenesis of bacterial meningitis, we investigated the ability of pentoxifylline to modulate meningeal inflammation in the rabbit meningitis model. Pentoxifylline treatment (initially an intravenous injection of 20 mg/kg followed by 6 mg/kg per h) started 20 min before intracisternal injection of 20 ng of Haemophilis influenzae type b lipooligosaccharide (endotoxin) reduced significantly concentrations in cerebrospinal fluid of leukocytes (P < 0.0001), protein (P < 0.001), and lactate (P < 0.001) during the 9-h infusion compared with values in intravenous-saline-treated rabbits. When pentoxifylline was given 1 h after H. influenzae type b endotoxin, the mean peak lactate and leukocyte concentrations in cerebrospinal fluid were significantly lower than those in control animals. Pentoxifylline also significantly decreased lactate and protein concentrations (P < 0.05) and tended to diminish leukocyte counts (P = 0.08) compared with results in control animals after antibiotic-induced release of endotoxin in animals with H. influenzae meningitis. In this regard, dexamethasone was superior to pentoxifylline and no synergism was observed when the drugs were combined. Additionally, pentoxifylline attenuated meningeal inflammatory changes induced by intracisternal inoculation of 10 ng of rabbit recombinant IL-1β compared with results in either dexamethasone- or saline-treated animals. We conclude that pentoxifylline is effective in this animal model in modulating the meningeal inflammatory response following intracisternal inoculation of H. influenzae type b endotoxin or organisms or rabbit recombinant IL-1β.

Original languageEnglish (US)
Pages (from-to)837-843
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume34
Issue number5
StatePublished - 1990

Fingerprint

Pentoxifylline
Bacterial Meningitides
Inflammation
Endotoxins
Human Influenza
Leukocytes
Interleukin-1
Rabbits
Lactic Acid
Meningitis
Dexamethasone
Cerebrospinal Fluid
Tumor Necrosis Factor-alpha
Proteins
Leukocyte Count
Intravenous Injections
Animal Models
Cytokines
Anti-Bacterial Agents
Injections

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Saez-Llorens, X., Ramilo, O., Mustafa, M. M., Mertsola, J., De Alba, C., Hansen, E., & McCracken, G. H. (1990). Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrobial Agents and Chemotherapy, 34(5), 837-843.

Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. / Saez-Llorens, X.; Ramilo, O.; Mustafa, M. M.; Mertsola, J.; De Alba, C.; Hansen, E.; McCracken, G. H.

In: Antimicrobial Agents and Chemotherapy, Vol. 34, No. 5, 1990, p. 837-843.

Research output: Contribution to journalArticle

Saez-Llorens, X, Ramilo, O, Mustafa, MM, Mertsola, J, De Alba, C, Hansen, E & McCracken, GH 1990, 'Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis', Antimicrobial Agents and Chemotherapy, vol. 34, no. 5, pp. 837-843.
Saez-Llorens X, Ramilo O, Mustafa MM, Mertsola J, De Alba C, Hansen E et al. Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrobial Agents and Chemotherapy. 1990;34(5):837-843.
Saez-Llorens, X. ; Ramilo, O. ; Mustafa, M. M. ; Mertsola, J. ; De Alba, C. ; Hansen, E. ; McCracken, G. H. / Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. In: Antimicrobial Agents and Chemotherapy. 1990 ; Vol. 34, No. 5. pp. 837-843.
@article{204c055f0cb04e4ea5e8fd38229603dd,
title = "Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis",
abstract = "Pentoxifylline has been shown to decrease endotoxin-induced tumor necrosis factor alpha production and reverse the inflammatory actions of interleukin-1 (IL-1) and tumor necrosis factor on leukocyte function. Because of the potential role of this cytokine-leukocyte interaction in the pathogenesis of bacterial meningitis, we investigated the ability of pentoxifylline to modulate meningeal inflammation in the rabbit meningitis model. Pentoxifylline treatment (initially an intravenous injection of 20 mg/kg followed by 6 mg/kg per h) started 20 min before intracisternal injection of 20 ng of Haemophilis influenzae type b lipooligosaccharide (endotoxin) reduced significantly concentrations in cerebrospinal fluid of leukocytes (P < 0.0001), protein (P < 0.001), and lactate (P < 0.001) during the 9-h infusion compared with values in intravenous-saline-treated rabbits. When pentoxifylline was given 1 h after H. influenzae type b endotoxin, the mean peak lactate and leukocyte concentrations in cerebrospinal fluid were significantly lower than those in control animals. Pentoxifylline also significantly decreased lactate and protein concentrations (P < 0.05) and tended to diminish leukocyte counts (P = 0.08) compared with results in control animals after antibiotic-induced release of endotoxin in animals with H. influenzae meningitis. In this regard, dexamethasone was superior to pentoxifylline and no synergism was observed when the drugs were combined. Additionally, pentoxifylline attenuated meningeal inflammatory changes induced by intracisternal inoculation of 10 ng of rabbit recombinant IL-1β compared with results in either dexamethasone- or saline-treated animals. We conclude that pentoxifylline is effective in this animal model in modulating the meningeal inflammatory response following intracisternal inoculation of H. influenzae type b endotoxin or organisms or rabbit recombinant IL-1β.",
author = "X. Saez-Llorens and O. Ramilo and Mustafa, {M. M.} and J. Mertsola and {De Alba}, C. and E. Hansen and McCracken, {G. H.}",
year = "1990",
language = "English (US)",
volume = "34",
pages = "837--843",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis

AU - Saez-Llorens, X.

AU - Ramilo, O.

AU - Mustafa, M. M.

AU - Mertsola, J.

AU - De Alba, C.

AU - Hansen, E.

AU - McCracken, G. H.

PY - 1990

Y1 - 1990

N2 - Pentoxifylline has been shown to decrease endotoxin-induced tumor necrosis factor alpha production and reverse the inflammatory actions of interleukin-1 (IL-1) and tumor necrosis factor on leukocyte function. Because of the potential role of this cytokine-leukocyte interaction in the pathogenesis of bacterial meningitis, we investigated the ability of pentoxifylline to modulate meningeal inflammation in the rabbit meningitis model. Pentoxifylline treatment (initially an intravenous injection of 20 mg/kg followed by 6 mg/kg per h) started 20 min before intracisternal injection of 20 ng of Haemophilis influenzae type b lipooligosaccharide (endotoxin) reduced significantly concentrations in cerebrospinal fluid of leukocytes (P < 0.0001), protein (P < 0.001), and lactate (P < 0.001) during the 9-h infusion compared with values in intravenous-saline-treated rabbits. When pentoxifylline was given 1 h after H. influenzae type b endotoxin, the mean peak lactate and leukocyte concentrations in cerebrospinal fluid were significantly lower than those in control animals. Pentoxifylline also significantly decreased lactate and protein concentrations (P < 0.05) and tended to diminish leukocyte counts (P = 0.08) compared with results in control animals after antibiotic-induced release of endotoxin in animals with H. influenzae meningitis. In this regard, dexamethasone was superior to pentoxifylline and no synergism was observed when the drugs were combined. Additionally, pentoxifylline attenuated meningeal inflammatory changes induced by intracisternal inoculation of 10 ng of rabbit recombinant IL-1β compared with results in either dexamethasone- or saline-treated animals. We conclude that pentoxifylline is effective in this animal model in modulating the meningeal inflammatory response following intracisternal inoculation of H. influenzae type b endotoxin or organisms or rabbit recombinant IL-1β.

AB - Pentoxifylline has been shown to decrease endotoxin-induced tumor necrosis factor alpha production and reverse the inflammatory actions of interleukin-1 (IL-1) and tumor necrosis factor on leukocyte function. Because of the potential role of this cytokine-leukocyte interaction in the pathogenesis of bacterial meningitis, we investigated the ability of pentoxifylline to modulate meningeal inflammation in the rabbit meningitis model. Pentoxifylline treatment (initially an intravenous injection of 20 mg/kg followed by 6 mg/kg per h) started 20 min before intracisternal injection of 20 ng of Haemophilis influenzae type b lipooligosaccharide (endotoxin) reduced significantly concentrations in cerebrospinal fluid of leukocytes (P < 0.0001), protein (P < 0.001), and lactate (P < 0.001) during the 9-h infusion compared with values in intravenous-saline-treated rabbits. When pentoxifylline was given 1 h after H. influenzae type b endotoxin, the mean peak lactate and leukocyte concentrations in cerebrospinal fluid were significantly lower than those in control animals. Pentoxifylline also significantly decreased lactate and protein concentrations (P < 0.05) and tended to diminish leukocyte counts (P = 0.08) compared with results in control animals after antibiotic-induced release of endotoxin in animals with H. influenzae meningitis. In this regard, dexamethasone was superior to pentoxifylline and no synergism was observed when the drugs were combined. Additionally, pentoxifylline attenuated meningeal inflammatory changes induced by intracisternal inoculation of 10 ng of rabbit recombinant IL-1β compared with results in either dexamethasone- or saline-treated animals. We conclude that pentoxifylline is effective in this animal model in modulating the meningeal inflammatory response following intracisternal inoculation of H. influenzae type b endotoxin or organisms or rabbit recombinant IL-1β.

UR - http://www.scopus.com/inward/record.url?scp=0025271786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025271786&partnerID=8YFLogxK

M3 - Article

C2 - 2360822

AN - SCOPUS:0025271786

VL - 34

SP - 837

EP - 843

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -